ADAM10 and pancreatic neoplasm: Gemcitabine showed anti-cancer effect by down-regulating NK cells function via inhibition of ADAM10 expression and shedding of sULBP2, which broadens our previous understanding of gemcitabine in the treatment of pancreatic cancer.